Elsevier Inc.

SHERPA: Unknown

People

  1. Riely
    Riely
  2. Wu
    Wu
  3. Yu
    Yu
  4. Zhang
    Zhang
  5. Patel
    Patel
  6. Yamada
    Yamada

Groups

  1. Biostatistics Service (5)
  2. Department of Medicine (5)
  3. Epidemiology and Biostatistics (5)
  4. Radiation Oncology, Department of (5)
  5. Solid Tumor Oncology Division (5)
  6. Thoracic Oncology (5)
  7. Surgery (4)
  8. Survivorship Research (4)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  10. GSK Faculty (1)
Search Within
  1. "Andreas Rimner"
  2. "Helena Yu"
  3. "International Journal of Radiation Oncology, Biology, Physics"
  4. "Epidemiology and Biostatistics"
  5. "Zhigang Zhang"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Biostatistics Service (5)
  2. Department of Medicine (5)
  3. Epidemiology and Biostatistics (5)
  4. Radiation Oncology, Department of (5)
  5. Solid Tumor Oncology Division (5)
  6. Thoracic Oncology (5)

More Groups

People
  1. Abraham Wu (5)
  2. Andreas Rimner (5)
  3. Gregory Riely (5)
  4. Helena Yu (5)
  5. Zhigang Zhang (5)
  6. Amanda Foster (4)

More People

Years
  1. 2014 (5)
Publications
  1. International Journal of Radiation Oncology, Biology, Physics (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pattern of failure in metastatic EGFR-mutant NSCLC treated with erlotinib: A role for upfront radiation therapy?
    Meeting Abstract

    Patel, S.; Rimner, A.; Foster, A.; Zhang, Z.; Woo, K. M.; Yu, H. A.; Riely, G. J.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Risk of brain metastasis in EGFR-mutant NSCLC treated with erlotinib: A role for prophylactic cranial irradiation?
    Meeting Abstract

    Patel, S.; Rimner, A.; Foster, A.; Zhang, Z.; Woo, K. M.; Yu, H. A.; Riely, G. J.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Pattern of failure in metastatic EGFR-mutant NSCLC treated with erlotinib: A role for upfront radiation therapy?
    Meeting Abstract

    Patel, S.; Rimner, A.; Foster, A.; Zhang, Z.; Woo, K. M.; Yu, H. A.; Riely, G. J.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Risk of brain metastasis in EGFR-mutant NSCLC treated with erlotinib: A role for prophylactic cranial irradiation?
    Meeting Abstract

    Patel, S.; Rimner, A.; Foster, A.; Zhang, Z.; Woo, K. M.; Yu, H. A.; Riely, G. J.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Erlotinib versus radiation therapy for brain metastases in patients with EGFR-mutant lung adenocarcinoma
    Journal Article

    Gerber, N. K.; Yamada, Y.; Rimner, A.; Shi, W.; Riely, G. J.; Beal, K.; Yu, H. A.; Chan, T. A.; Zhang, Z.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save